Cardiff Oncology (NASDAQ: CRDF)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cardiff Oncology (NASDAQ: CRDF) through any online brokerage.
The latest price target for Cardiff Oncology (NASDAQ: CRDF) was reported by HC Wainwright & Co. on Monday, May 9, 2022. The analyst firm set a price target for 22.00 expecting CRDF to rise to within 12 months (a possible 730.19% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.65 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.